Correlation Between Clarity Pharmaceuticals and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Clarity Pharmaceuticals and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clarity Pharmaceuticals and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clarity Pharmaceuticals and MAIA Biotechnology, you can compare the effects of market volatilities on Clarity Pharmaceuticals and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clarity Pharmaceuticals with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clarity Pharmaceuticals and MAIA Biotechnology.
Diversification Opportunities for Clarity Pharmaceuticals and MAIA Biotechnology
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Clarity and MAIA is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Clarity Pharmaceuticals and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Clarity Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clarity Pharmaceuticals are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Clarity Pharmaceuticals i.e., Clarity Pharmaceuticals and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Clarity Pharmaceuticals and MAIA Biotechnology
Assuming the 90 days horizon Clarity Pharmaceuticals is expected to generate 0.8 times more return on investment than MAIA Biotechnology. However, Clarity Pharmaceuticals is 1.24 times less risky than MAIA Biotechnology. It trades about 0.08 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about 0.0 per unit of risk. If you would invest 61.00 in Clarity Pharmaceuticals on November 5, 2024 and sell it today you would earn a total of 179.00 from holding Clarity Pharmaceuticals or generate 293.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 98.38% |
| Values | Daily Returns |
Clarity Pharmaceuticals vs. MAIA Biotechnology
Performance |
| Timeline |
| Clarity Pharmaceuticals |
| MAIA Biotechnology |
Clarity Pharmaceuticals and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Clarity Pharmaceuticals and MAIA Biotechnology
The main advantage of trading using opposite Clarity Pharmaceuticals and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clarity Pharmaceuticals position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Clarity Pharmaceuticals vs. Two Harbors Investments | Clarity Pharmaceuticals vs. Ecovyst | Clarity Pharmaceuticals vs. X FAB Silicon Foundries | Clarity Pharmaceuticals vs. Luxfer Holdings PLC |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |